India’s Pharma sector falters in H1 2025; index falls over 6% becoming the second worst-performing sector

India's pharmaceutical sector faced a 6% decline in the Nifty Pharma index in 2025, while the Nifty 50 index rose 8%. Major firms experienced significant losses, though some companies like Laurus Labs and Abbott India saw gains amid investor concerns over tariffs and macroeconomic issues.

Markets